Drug Research

Maybe you’ve noticed: medications are getting more complicated, more personalized, and more expensive. Look at some of the recent drugs approved for cancer, hepatitis C virus, or rheumatoid arthritis. These are three very different conditions, but many newer drugs used...

Symptoms People with type 1 or type 2 diabetes may have a range of symptoms. These symptoms might include: Frequent urination (polyuria) -- often at night (nocturia) Excessive thirst (polydipsia) Extreme hunger (polyphagia) Dry skin Weakness/feeling tired much of the...

Risk Factors Risk factors are characteristics that can predispose you to developing a condition or disease. Just because you have one or more risk factors does not mean you will get diabetes. Risk factors for type 1 diabetes are not...

Neos Therapeutics, Inc, a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD) announced that the U.S. FDA approved Adzenys XR-ODT for the treatment of ADHD in patients six...

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is...

Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups. Teva's Dedication and Commitment Recognized by Patients According to 165 patient groups with an interest in neurological conditions,...

AstraZeneca and Cancer Research UK today announced that they have signed a memorandum of understanding through which Cancer Research UK drug discovery investigators would be given access to state-of-the-art drug discovery facilities at the new AstraZeneca MRC UK Centre...